Key Takeaways
- The ADA defines remission as A1C below 6.5% (48 mmol/mol) for at least 3 months without glucose-lowering medications. It doesn't mean the condition is gone permanently.[1]
- In the DiRECT trial, 46% of participants achieved remission at 1 year through structured weight management, with 86% remission among those who lost 15 kg or more.[2]
- Weight regain is the strongest predictor of relapse. Ongoing monitoring and lifestyle maintenance remain essential.
- Earlier diagnosis, greater weight loss, and higher remaining beta-cell function are associated with better remission outcomes.
UK readers: mg/dL values can be converted to mmol/L by dividing by 18. HbA1c percentages appear with mmol/mol equivalents where space allows. For UK-specific guidance, Diabetes UK and NICE are reliable sources.
"Can you reverse diabetes?" is one of the most searched health questions on the internet. It's also one of the most misleading, because the word "reverse" implies a permanent fix. The medical community increasingly prefers the word "remission," which more accurately describes what the research shows: some people can bring their blood sugar levels back into a normal range through sustained lifestyle changes, but the underlying tendency doesn't disappear. Related reading: diabetes technology and tools.
What remission actually means, which trials have demonstrated it, who is most likely to achieve it, and what it takes to sustain it, the DiRECT trial, the Diabetes Prevention Program, bariatric surgery data, and the biological reasons remission is possible for some but not others. For a deeper dive, see our guide on whether diabetes runs in your family.
Important note: managing blood sugar levels into remission requires medical supervision. None of what follows is a substitute for working closely with your healthcare team.
What Does Diabetes Remission Actually Mean?
In 2021, the American Diabetes Association published a consensus statement defining remission as an A1C below 6.5% maintained for at least 3 months without glucose-lowering medications.[1] This replaced older, less consistent definitions that varied across studies. The term "remission" was chosen deliberately over "cure" or similar language because blood sugar levels can rise again, especially if lifestyle changes aren't sustained.
Why "remission" and not something stronger
Cancer medicine offers a useful comparison. Cancer patients in remission continue monitoring because the disease can return. The same principle applies to type 2 diabetes. Even when glucose levels normalize, the beta-cell vulnerability and insulin resistance tendencies often persist at some level. A study in The Lancet found that among people who achieved remission in the DiRECT trial, about a quarter had relapsed by year two.[3] Remission is real, but it requires ongoing vigilance.
The spectrum of outcomes
Not everyone who improves their blood sugar achieves formal remission. Many people significantly lower their A1C, reduce medications, and improve quality of life without hitting the technical threshold. Research from the Look AHEAD trial found that even participants who didn't achieve full remission had meaningful reductions in cardiovascular risk factors through lifestyle changes.[4] Partial improvement still matters enormously for long-term health.
If your goal is remission, discuss it openly with your doctor. They can help you set realistic timelines, identify your baseline beta-cell function (via C-peptide testing), and create a structured plan. People who work with a healthcare team, including a dietitian, tend to achieve better outcomes than those who try to manage independently.[5]
What Did the DiRECT Trial Show?
The Diabetes Remission Clinical Trial (DiRECT) is the most important study on this topic. Published in The Lancet in 2018, it enrolled 298 adults in the UK with type 2 diabetes diagnosed within the past 6 years. At 1 year, 46% of participants in the intervention group achieved remission, compared to 4% in the control group.[2] Those are striking numbers that fundamentally shifted how the medical community thinks about type 2 diabetes.
How the intervention worked
The DiRECT protocol involved three phases. First, participants stopped their diabetes medications under supervision and began an 800-calorie per day formula diet (shakes and soups) for 12-20 weeks. Second, food was reintroduced gradually over 2-8 weeks. Third, participants entered a long-term weight maintenance phase with structured support.[2] This wasn't a casual diet. It was a medically supervised program with regular check-ins.
The weight loss dose-response
The relationship between weight loss and remission was remarkably clear. Among participants who lost 0-5 kg, only 7% achieved remission. For 5-10 kg of loss, the rate was 34%. For 10-15 kg, it was 57%. And among those who lost 15 kg or more, the remission rate reached 86%.[2] This dose-response pattern strongly suggests that fat loss in the liver and pancreas is the mechanism driving remission.
Two-year results
At two years, 36% of participants remained in remission, down from 46% at one year.[3] Weight regain was the primary predictor of relapse. Participants who maintained their weight loss maintained remission at much higher rates. This finding highlights both the promise and the challenge: achieving remission is possible, but sustaining it requires sustained effort.
How Does the Diabetes Prevention Program Fit In?
The Diabetes Prevention Program (DPP) studied people with prediabetes, not established diabetes, but its findings are directly relevant. Over about 3 years, the lifestyle intervention group (which targeted 7% weight loss and 150 minutes of weekly exercise) reduced their progression to type 2 diabetes by 58%.[6] That's a prevention study, not a remission study, but it demonstrates how responsive early-stage glucose dysregulation is to lifestyle changes.
Long-term DPP follow-up
The DPP Outcomes Study followed participants for 15 years. The lifestyle group maintained a 27% lower rate of diabetes compared to placebo, even though the intensive intervention only lasted about 3 years.[7] This suggests that even a time-limited period of focused lifestyle change can have lasting effects on glucose metabolism. The earlier you intervene, the more impact each effort may have.
What DPP teaches about timing
Both DPP and DiRECT enrolled people relatively early in their glucose dysregulation journey. DPP focused on prediabetes. DiRECT required diagnosis within 6 years. The common finding is that earlier intervention, before extensive beta-cell damage has occurred, offers the best chance of meaningful improvement. Beta cells in the pancreas have limited regenerative capacity, so protecting them early matters.[8]
If you've been recently diagnosed with type 2 diabetes or prediabetes, you're in the best position to make an impact. Research consistently shows that the first few years after diagnosis offer the widest window for meaningful glucose improvement. Don't wait. Talk to your healthcare provider about a structured plan that includes dietary changes, physical activity, and regular monitoring.[2]
What Role Does Bariatric Surgery Play in Remission?
Bariatric surgery produces the highest remission rates of any intervention studied. A meta-analysis in Obesity Surgery found that roughly 72% of patients with type 2 diabetes achieved remission after bariatric surgery.[9] Roux-en-Y gastric bypass showed higher rates than sleeve gastrectomy, and both far exceeded what lifestyle interventions alone achieve. However, surgery carries its own risks and isn't appropriate for everyone.
Why surgery works so well
Bariatric surgery produces rapid, substantial weight loss, but it also changes gut hormones in ways that go beyond what weight loss alone explains. GLP-1 levels increase dramatically after Roux-en-Y, which may support insulin secretion and glucose control independently of weight.[10] Bile acid changes and shifts in the gut microbiome also contribute. Some patients see glucose normalization within days of surgery, before significant weight loss has occurred.
Long-term durability
Remission after bariatric surgery isn't always permanent. A study in Diabetes Care followed patients for 5 years and found that about 35-50% experienced some degree of relapse, though most still had better glucose control than before surgery.[11] Longer diabetes duration before surgery predicted higher relapse rates. This again shows the theme: earlier intervention tends to produce more durable results.
Who's a candidate
Current guidelines generally recommend bariatric surgery for people with type 2 diabetes and a BMI of 35 or above, or a BMI of 30-34.9 with inadequately controlled blood sugar despite medical therapy. The American Diabetes Association includes metabolic surgery in its Standards of Care as a treatment option for appropriate candidates.[12] It's not a first-line approach, but for some people it can be genuinely significant.
What Biological Factors Determine Who Can Achieve Remission?
The twin cycle hypothesis, proposed by Professor Roy Taylor at Newcastle University, provides the clearest framework. It suggests that excess fat in the liver drives insulin resistance and excess fat in the pancreas impairs beta-cell function. When both are reduced through weight loss, glucose homeostasis can be restored in people with sufficient remaining beta-cell mass.[13] Research using MRI scans has confirmed significant reductions in liver and pancreatic fat among DiRECT participants who achieved remission.
Beta-cell function is the key variable
Not everyone responds equally to weight loss because beta-cell damage varies. People diagnosed more recently tend to have more functional beta cells remaining. A study in Cell Metabolism found that participants who achieved remission in DiRECT had significantly higher beta-cell function (measured by stimulated C-peptide) at baseline compared to those who didn't.[14] Once too many beta cells are lost, the window narrows considerably.
The personal fat threshold
Professor Taylor's group also proposed the concept of a "personal fat threshold," the idea that each person has an individual limit of fat they can carry before it spills into the liver and pancreas. This helps explain why some people develop type 2 diabetes at a BMI of 26 while others remain glucose-normal at 35. It's not about total body fat. It's about where that fat accumulates relative to your personal threshold.[15]
Genetics and ethnicity
Genetic factors influence both beta-cell resilience and fat distribution patterns. People of South Asian, East Asian, and African descent tend to develop insulin resistance and beta-cell dysfunction at lower BMI levels compared to people of European descent, according to research in The Lancet Diabetes & Endocrinology.[16] This doesn't mean remission isn't possible, but it may mean the approach needs to be tailored.
If you want to understand your remaining beta-cell function, ask your doctor about a fasting C-peptide test. C-peptide is released alongside insulin and provides a more stable measure of how much insulin your pancreas is still producing. Higher C-peptide levels generally indicate better potential for achieving remission through weight management.[14]
What Lifestyle Changes Support Remission Efforts?
The Diabetes Prevention Program found that 150 minutes of moderate-intensity exercise per week, combined with 7% weight loss, reduced diabetes progression by 58%.[6] For people already diagnosed, the evidence points to similar strategies but with more intensity. Weight loss of at least 10-15 kg appears necessary for remission in most cases. Here's what the evidence says about specific approaches.
Calorie reduction strategies
The DiRECT trial used a total diet replacement approach (800 calories per day of formula products). Other research has shown that low-calorie diets using conventional foods can also produce significant glucose improvements, though adherence tends to be lower. A study in Diabetic Medicine found that a 600-calorie deficit per day using regular meals produced meaningful A1C reductions over 12 weeks, though not as dramatic as total diet replacement.[17]
Exercise and insulin sensitivity
Exercise supports remission efforts primarily by improving insulin sensitivity in muscle and liver cells. Research in Sports Medicine found that both aerobic and resistance training improve insulin sensitivity for up to 48 hours after each session.[18] Exercise alone rarely produces enough weight loss for remission, but it enhances the glucose-lowering effects of dietary changes and helps maintain weight loss over time.
Sleep and stress management
Chronic sleep deprivation impairs insulin sensitivity. Research in The Lancet showed that sleeping 4 hours per night for 6 nights reduced insulin sensitivity by roughly 40%.[19] Stress similarly raises cortisol, which increases glucose output from the liver. Neither sleep nor stress management alone will produce remission, but neglecting them can undermine otherwise good dietary and exercise habits.
What Are the Limitations and Realistic Expectations?
Remission isn't achievable for everyone, and suggesting otherwise would be irresponsible. The Look AHEAD trial, which followed over 5,000 adults with type 2 diabetes for up to 8 years, found that only about 7% were in partial or complete remission at the 4-year mark, despite significant lifestyle efforts.[20] The participants had longer diabetes duration than DiRECT, which likely explains the lower rates. Reality is more specific than headlines suggest.
Duration of diabetes matters
DiRECT enrolled people diagnosed within 6 years. Look AHEAD had no such restriction. The consistent finding across studies is that people diagnosed more recently have better remission prospects. Beta-cell function declines progressively over time, and once enough beta cells are lost, even significant weight loss may not restore normal glucose handling.[8]
The maintenance challenge
Weight maintenance is the hardest part of any weight loss effort. Research in Obesity Reviews found that most people regain 30-50% of lost weight within 2 years of any dietary intervention.[21] This isn't a character flaw. It reflects biological adaptations (reduced metabolic rate, increased hunger hormones) that make sustained weight loss genuinely difficult. Long-term support systems are essential.
Every improvement matters
Even if full remission isn't achieved, every A1C point reduced lowers complication risk. The UKPDS found that each 1% reduction in A1C was associated with a 37% decrease in microvascular complications and a 21% decrease in diabetes-related death.[22] Moving from an A1C of 9% to 7.5% (58 mmol/mol) is enormously beneficial, even if it doesn't technically qualify as remission. Progress is the goal, not perfection.
Putting It All Together
Type 2 diabetes remission is genuinely possible for some people, especially those diagnosed recently, with remaining beta-cell function, and who achieve significant weight loss. The DiRECT trial showed that 46% remission is achievable with structured support. Bariatric surgery offers even higher rates. But remission requires sustained effort and ongoing medical monitoring. For a deeper dive, see our guide on the diabetes and oral health connection.
The word "remission" matters. It carries both hope and honesty. Hope because the condition doesn't have to be a one-way street. Honesty because it's not a permanent fix, and the underlying tendencies remain. Think of remission as a state you actively maintain, not a box you check and move on from. For a deeper dive, see our guide on how diabetes affects your eyes.
If you're interested in working toward remission, start with your healthcare provider. Get your baseline numbers, discuss your beta-cell function, and create a realistic plan. Whether you achieve formal remission or meaningful improvement, every step toward better glucose management is worth taking. For a deeper dive, see our guide on one family member on watching a parent with diabetes.
What Customers Tell Us
"Fasting numbers have been steadier since I added Diabec alongside my walking routine. I still see my doctor, still take my meds, this feels like a helpful addition."
"I appreciated that the label tells you what six herbs are inside and why. My GP was fine with it once she saw the ingredient list."
Individual experiences are personal reports, not typical results. Diabec is a food supplement and does not treat, cure, or prevent any disease.
Support Your Glucose Wellness Naturally
Diabec combines six Ayurvedic herbs, including Bitter Melon, Gymnema, and Fenugreek, traditionally used alongside lifestyle changes to support healthy glucose metabolism.
Support Healthy Blood Sugar NaturallyDisclaimer: These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is educational and does not constitute medical advice. Work closely with your healthcare team on any remission-focused plan.
Sources & References
- Riddle, M. C., Cefalu, W. T., Evans, P. H., et al. (2021). Consensus report: definition and interpretation of remission in type 2 diabetes. Diabetes Care, 44(10), 2438-2444. PMID: 34462270
- Lean, M. E., Leslie, W. S., Barnes, A. C., et al. (2018). Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. The Lancet, 391(10120), 541-551. PMID: 29221645
- Lean, M. E., Leslie, W. S., Barnes, A. C., et al. (2019). Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT trial. The Lancet Diabetes & Endocrinology, 7(5), 344-355. PMID: 30852132
- Look AHEAD Research Group. (2013). Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. New England Journal of Medicine, 369(2), 145-154. PMID: 23796131
- Greaves, C. J., Sheppard, K. E., Abraham, C., et al. (2011). Systematic review of reviews of intervention components associated with increased effectiveness in dietary and physical activity interventions. BMC Public Health, 11, 119. PMID: 21333011
- Knowler, W. C., Barrett-Connor, E., Fowler, S. E., et al. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346(6), 393-403. PMID: 11832527
- Diabetes Prevention Program Research Group. (2015). Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications. The Lancet Diabetes & Endocrinology, 3(11), 866-875. PMID: 26377054
- UKPDS Group. (1995). U.K. Prospective Diabetes Study 16: Overview of 6 years' therapy of type II diabetes. Diabetes, 44(11), 1249-1258. PMID: 7589820
- Buchwald, H., Estok, R., Fahrbach, K., et al. (2009). Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. American Journal of Medicine, 122(3), 248-256. PMID: 19272486
- Jorgensen, N. B., Dirksen, C., Bojsen-Moller, K. N., et al. (2013). Exaggerated glucagon-like peptide 1 response is important for improved beta-cell function and glucose tolerance after Roux-en-Y gastric bypass. Diabetes, 62(9), 3044-3052. PMID: 23649520
- Brethauer, S. A., Aminian, A., Romero-Talamas, H., et al. (2013). Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery. Annals of Surgery, 258(4), 628-637. PMID: 24018646
- American Diabetes Association Professional Practice Committee. (2024). Standards of Care in Diabetes - 2024. Diabetes Care, 47(Suppl 1). ADA Standards 2024
- Taylor, R. (2013). Type 2 diabetes: etiology and reversibility. Diabetes Care, 36(4), 1047-1055. PMID: 23520370
- Taylor, R., Al-Mrabeh, A., Zhyzhneuskaya, S., et al. (2018). Remission of human type 2 diabetes requires decrease in liver and pancreas fat content but is dependent upon capacity for beta cell recovery. Cell Metabolism, 28(4), 547-556. PMID: 30078554
- Taylor, R., & Holman, R. R. (2015). Normal weight individuals who develop type 2 diabetes: the personal fat threshold. Clinical Science, 128(7), 405-410. PMID: 25515001
- Sattar, N., & Gill, J. M. R. (2015). Type 2 diabetes in migrant south Asians: mechanisms, mitigation, and management. The Lancet Diabetes & Endocrinology, 3(12), 1004-1016. PMID: 26489808
- Steven, S., Hollingsworth, K. G., Al-Mrabeh, A., et al. (2016). Very low-calorie diet and 6 months of weight stability in type 2 diabetes. Diabetes Care, 39(5), 808-815. PMID: 27002059
- Borghouts, L. B., & Keizer, H. A. (2000). Exercise and insulin sensitivity: a review. International Journal of Sports Medicine, 21(1), 1-12. PMID: 10683091
- Spiegel, K., Leproult, R., & Van Cauter, E. (1999). Impact of sleep debt on metabolic and endocrine function. The Lancet, 354(9188), 1435-1439. PMID: 10543671
- Gregg, E. W., Chen, H., Wagenknecht, L. E., et al. (2012). Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA, 308(23), 2489-2496. PMID: 23288372
- Anderson, J. W., Konz, E. C., Frederich, R. C., & Wood, C. L. (2001). Long-term weight-loss maintenance: a meta-analysis of US studies. American Journal of Clinical Nutrition, 74(5), 579-584. PMID: 11684524
- Stratton, I. M., Adler, A. I., Neil, H. A., et al. (2000). Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35). BMJ, 321(7258), 405-412. PMID: 10938048
- CDC. (2022). National Diabetes Statistics Report. CDC
- Hu, F. B., et al. (2001). Diet, lifestyle, and the risk of type 2 diabetes in women. NEJM, 345(11), 790-797. PMID: 11556298
- DeFronzo, R. A. (2009). From the triumvirate to the ominous octet. Diabetes, 58(4), 773-795. PMID: 19336687
- Hallberg, S. J., McKenzie, A. L., Williams, P. T., et al. (2018). Effectiveness and safety of a novel care model for the management of type 2 diabetes at 1 year. Diabetes Therapy, 9(2), 583-612. PMID: 29417495
- Mingrone, G., Panunzi, S., De Gaetano, A., et al. (2015). Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. The Lancet, 386(9997), 964-973. PMID: 26369473
- Schauer, P. R., Bhatt, D. L., Kirwan, J. P., et al. (2017). Bariatric surgery versus intensive medical therapy for diabetes, 5-year outcomes. New England Journal of Medicine, 376(7), 641-651. PMID: 28199805
- Lim, E. L., Hollingsworth, K. G., Aribisala, B. S., et al. (2011). Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia, 54(10), 2506-2514. PMID: 21656330
- Steven, S., & Taylor, R. (2015). Restoring normoglycaemia by use of a very low calorie diet in long- and short-duration Type 2 diabetes. Diabetic Medicine, 32(9), 1149-1155. PMID: 25683066